Maximilian Siebert

Max is a trained pharmacist who completed his studies at the University of Regensburg, Germany. In 2018, he earned an MSc in Clinical Evaluation from the University of Lyon and subsequently pursued a PhD at the University of Rennes, where he focused on the reproducibility of therapeutic research under the supervision of Florian Naudet.

Following his fellowship at METRICS, he is currently a fellow at the Harvard-MIT Center for Regulatory Science. In this role, he is concentrating on Postmarketing Requirements set by the FDA.

Max's primary research interests include open science, data sharing, regulatory decision-making, as well as health policy, global health, and the improvement of clinical research practices.